Welcome to our dedicated page for ESSILOR LXTTCA news (Ticker: ESLOY), a resource for investors and traders seeking the latest updates and insights on ESSILOR LXTTCA stock.
The ESLOY news page tracks announcements and developments related to EssilorLuxottica, a global group active in advanced vision care products, eyewear and med-tech solutions. Company communications highlight activities that span lens technologies, eyewear brands, smart glasses and large retail networks, which generate a steady flow of news for investors and observers.
Recent news has featured the launch of Nuance Audio Glasses, described as an invisible open-ear hearing solution integrated into eyewear for adults with perceived mild to moderate hearing loss. These smart glasses are presented as FDA-registered over-the-counter hearing aids in the U.S., combining directional microphones, open-ear speakers and beamforming technology in a lightweight frame. Updates around this product can include availability in different markets, product features and app capabilities.
EssilorLuxottica’s retail banners also generate news. Sunglass Hut, which is part of the group, has announced The Sun Club, a points-based loyalty program that rewards customers with points on purchases and engagement activities, and offers tiered benefits such as promotions, gifts with purchase, exclusive product launches and branded gifts. Such announcements illustrate how the group engages with eyewear consumers through marketing and loyalty initiatives.
On this ESLOY news page, readers can follow company press releases and related coverage tied to EssilorLuxottica’s vision care technologies, eyewear brands, med-tech products like Nuance Audio Glasses, and retail programs such as The Sun Club. Investors and industry followers may find it useful to monitor these updates to understand how the group presents its product launches, retail strategies and brand activities over time.
EssilorLuxottica (ESLOY) reports buybacks of 287,000 of its own shares on September 18, 2026, under an authorization from the April 28, 2026 shareholders’ meeting.
The shares, all bearing code FR0000121667, were repurchased across four venues: XPAR (188,650 shares at €139.3060), CEUX (74,150 shares at €139.2841), TQEX (9,825 shares at €139.2234) and AQEU (14,375 shares at €139.2167), at a total daily weighted average price of €139.2931 per share.
EssilorLuxottica (ESLOY) reported its share capital and voting rights outstanding as of August 31, 2026, in line with French regulatory requirements.
The company had 464,247,548 shares outstanding, with 459,153,735 real voting rights excluding treasury shares. Theoretical voting rights, including treasury shares, matched the total shares outstanding at 464,247,548. Voting rights for any single shareholder are capped at 31%, based on a formula set out in article 23 of the company’s by-laws.
EssilorLuxottica (ESLOY) announces that its Board of Directors has unanimously reaffirmed full confidence in Chairman and CEO Francesco Milleri, Deputy CEO Paul du Saillant, the executive team and the mid- and long-term strategy approved by the Board.
The Board links its support to the company’s strong results and states its commitment to preserving stability and a sense of responsibility in the interests of employees, shareholders, partners and customers.
EssilorLuxottica (ESLOY) reports share buybacks executed between August 31 and September 3, 2026 under the authorization granted by shareholders on April 28, 2026.
Over this period, the company repurchased a total of 424,681 shares of its stock, at a total daily weighted average purchase price of €159.0096 per share. Transactions were carried out in the financial instrument FR0000121667 across several trading venues, including XPAR, CEUX, TQEX and AQEU, with daily volumes and weighted average prices detailed for each venue and date.
EssilorLuxottica (ESLOY) reported its share capital and voting rights outstanding as of July 31, 2026. The company had 464,247,548 shares outstanding, with 459,591,833 real voting rights excluding treasury shares, and a theoretical total of 464,247,548 voting rights including treasury shares.
Voting rights for any shareholder are capped at 31%, based on a formula set out in article 23 of EssilorLuxottica’s by-laws, which are available on the company’s website.
EssilorLuxottica (OTC: ESLOY) reported transactions in its own shares under the authorization granted by the April 28, 2026 shareholders’ meeting. From August 25 to 27, 2026, the company repurchased a total of 300,335 shares at a daily weighted average price of €158.9668.
Buybacks were executed on several venues, including XPAR, CEUX, TQEX and AQEU, with individual daily volumes and prices disclosed for each market.
EssilorLuxottica (ESLOY) announced the launch of a share buyback program on August 28, 2026. The company has mandated an investment services provider to repurchase up to 5,000,000 shares, starting immediately, subject to market conditions and under the 19th resolution approved at the April 28, 2026 AGM.
EssilorLuxottica (OTC: ESLOY) reported transactions in its own shares carried out under the share buyback authorization granted by the April 28, 2026 shareholders’ meeting. Between August 17 and 21, 2026, the company repurchased 137,964 shares of ISIN FR0000121667 at a daily weighted average price of €159.8694 across several European trading venues.
EssilorLuxottica (ESLOY) announced that its Board of Directors met on July 28, 2026 to approve the condensed consolidated interim financial statements for the six months ended June 30, 2026. The 2026 Interim Financial Report, published on July 29, 2026, includes the First-half 2026 Management Report, Condensed Consolidated Interim Financial Statements, Statutory Auditors’ Review Report, and the Statement by the Person Responsible. According to EssilorLuxottica, the report is available on its website under Investors – Financial Publications.
EssilorLuxottica (ESLOY) reported H1 2026 revenue growth of 9.7% at constant exchange rates, with Q2 up 8.7%. Adjusted operating profit rose 15%, with adjusted operating margin reaching 18.6%, or 18.9% at constant exchange rates, expanding by 80 bps.
Q2 retail comparable-store sales grew 8.0%; North America, EMEA and Latin America increased high single digit, Asia-Pacific double digit. The myopia portfolio grew 24% in Q2 revenue, AI glasses nearly doubled, and H1 free cash flow reached €1.07 billion, over €100 million above 2025. The company also started a strategic partnership with Applied Materials on intelligent optical systems.